Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Epizyme, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 800K | Apr 1, 2022 | Direct | ||
Kaleido Biosciences, Inc. | COO & General Counsel | Restricted Stock Units | 4.52K | Feb 28, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EPZM | Epizyme, Inc. | Aug 12, 2022 | 0 | $0 | 4 | Aug 16, 2022 | Chief Operating Officer |
EPZM | Epizyme, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Chief Operating Officer |
EPZM | Epizyme, Inc. | Mar 21, 2022 | 0 | $0 | 3 | Mar 21, 2022 | Chief Operating Officer |
KLDO | Kaleido Biosciences, Inc. | Feb 28, 2022 | 1 | -$3.05K | 4 | Mar 2, 2022 | COO & General Counsel |
KLDO | Kaleido Biosciences, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | COO & General Counsel |
KLDO | Kaleido Biosciences, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 2, 2021 | General Counsel |